Adrenomedullin is a potent vasodilatory peptide with plasma levels that inc
rease during pregnancy. Although fetoplacental adrenomedullin levels are re
ported to increase in preeclampsia, maternal plasma levels may be elevated
or decreased, or they may resemble those in normal pregnancy. In other hype
rtensive conditions, adrenomedullin increases. Therefore, we hypothesized t
hat maternal plasma adrenomedullin levels would be higher in hypertensive p
regnancies than in normotensive pregnancies and that the higher placental r
esistance found in preeclamptic pregnancies results from blunted activity o
f adrenomedullin on the vasculature. Adrenomedullin concentrations in plasm
a from women with normotensive pregnancies, gestational hypertension, and p
reeclampsia were determined by radioimmunoassay. Stem villous arteries from
normotensive and preeclamptic pregnancies were dissected and mounted on a
wire myograph system. Arteries were first preconstricted to 80% of their ma
ximum constriction with U46619, a thromboxane A(2) mimetic, and exposed to
cumulative doses of adrenomedullin (1 X 10(-9) to 3 X 10(-7) mol/L). Contra
ry to our hypothesis, there were no significant differences in maternal pla
sma adrenomedullin levels among patients with normal pregnancies, gestation
al hypertension, and preeclampsia. Adrenomedullin significantly relaxed art
eries from both normal and preeclamptic placentas, but there was no signifi
cant difference between the 2 groups. During normal pregnancy, adrenomedull
in may contribute to the low placental vascular resistance. This pathway ap
pears to be intact in preeclampsia. We conclude that the increased placenta
l vascular resistance observed in preeclampsia is due neither to reduced ad
renomedullin secretion nor to an attenuated vascular responsiveness. Moreov
er, unlike other hypertensive disorders, there is no compensatory rise in c
irculating adrenomedullin levels.